p27a vaccine candidate
Vaccineexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2014 (NCT01949909)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- p27a vaccine candidate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01949909 | Phase 1 | Mar 1, 2014 | Bagamoyo Research and Training Center, European & Developing Countries Clinical Trials Partnership (EDCTP), European Vaccine Initiative (EVI), Heidelberg, Germany, University of Lausanne |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bagamoyo Research and Training Center | Academic/Hospital | 1 | 0 | 1 | 2014 |
| European & Developing Countries Clinical Trials Partnership (EDCTP) | Academic/Hospital | 1 | 0 | 1 | 2014 |
| European Vaccine Initiative (EVI), Heidelberg, Germany | Government | 1 | 0 | 1 | 2014 |
| University of Lausanne | Academic/Hospital | 1 | 1 | 1 | 2014 |
4 organizations
Page 1 / 1